M Tanaka
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria 6
- Pharmacology top 5%
- Antibiotics Pharmacokinetics and Efficacy 5
- Obstetrics and Gynecology top 10%
- Clinical Biochemistry top 10%
-
- Cancer therapeutics and mechanisms 7
- Mitochondrial Function and Pathology 2
-
- Monoclonal and Polyclonal Antibodies Research 3
-
- Bioactive Compounds and Antitumor Agents 2
-
- Cervical Cancer and HPV Research 2
-
- Synthesis and biological activity 1
M Tanaka
22 papers receiving 651 citations
Peers
Comparison fields: 5 of 87
- Molecular Medicine 186
- Pharmacology 200
- Obstetrics and Gynecology 66
- Infectious Diseases 108
- Clinical Biochemistry 39
Countries citing papers authored by M Tanaka
This map shows the geographic impact of M Tanaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Tanaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Tanaka more than expected).
Fields of papers citing papers by M Tanaka
This network shows the impact of papers produced by M Tanaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Tanaka. The network helps show where M Tanaka may publish in the future.
Co-authorship network
The 25 scholars most cited alongside M Tanaka, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 80 | |
| 2 | 1998 | 11 | |
| 3 | [A mitochondrial DNA mutation in the heteroplasmic tRNA-Tyr gene associated with chronic progressive external ophthalmoplegia--clinical and molecular biological study]. | 1997 | 4 |
| 4 | 1997 | 17 | |
| 5 | 1997 | 65 | |
| 6 | Mitochondrial DNA mutations associated with the 11778 mutation in Leber's disease. | 1996 | 6 |
| 7 | 1995 | 28 | |
| 8 | The effect of DU-6859a, a new potent fluoroquinolone, on fecal microflora in human volunteers. | 1995 | 7 |
| 9 | 1995 | 50 | |
| 10 | 1995 | 64 | |
| 11 | 1993 | 96 | |
| 12 | 1993 | 15 | |
| 13 | 1992 | 108 | |
| 14 | 1991 | 39 | |
| 15 | 1989 | 41 | |
| 16 | Effect of Cyclosporin A on rat thymus: time course analysis by immunoperoxidase technique and flow cytofluorometry. | 1988 | 17 |
| 17 | 1987 | 0 | |
| 18 | Regulation of IgE receptor expression on human peripheral blood lymphocytes by lymphocytosis promoting factor (LPF), lectins and dexamethasone. | 1987 | 9 |
| 19 | [Immunological study of Bacteroides melaninogenicus]. | 1970 | 1 |
| 20 | Development of cervical cancer in surgical cases; surgical pathology of cervical cancer. | 1956 | 1 |
About M Tanaka
M Tanaka is a scholar working on Molecular Medicine, Toxicology and Applied Microbiology and Biotechnology, having authored 23 papers that have together received 689 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (7 papers), Antibiotic Resistance in Bacteria (6 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Bioactive Compounds and Antitumor Agents (2 papers), Mitochondrial Function and Pathology (2 papers), Cervical Cancer and HPV Research (2 papers) and Synthesis and biological activity (1 paper). The work is most often cited by research in Molecular Medicine (186 citations), Pharmacology (200 citations) and Obstetrics and Gynecology (66 citations). M Tanaka has collaborated with scholars based in Japan, China and United States. Frequent co-authors include I Hayakawa, Y Osada, Kenichi Sato, Katsumasa Sato, Kazuki Hoshino, Yutaka Matsuura, M Kashimura, Naoyuki Toki, Toshinori Kawagoe and Yoshikuni Onodera. Their work appears in journals such as Journal of Biological Chemistry, The Journal of Immunology and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.